Que May Lan, Andersen Elene, Mombelli Andrea
School of Dental Medicine, University of Geneva, Switzerland.
J Clin Periodontol. 2004 Nov;31(11):978-84. doi: 10.1111/j.1600-051X.2004.00594.x.
The inflammatory myeloid-related protein, MRP8/14, also called calprotectin, and its subunits MRP8 and MRP14 have been detected and identified recently in gingival crevicular fluid (GCF). It has been suggested that the type and phase of inflammation can be discriminated on the basis of differences in the expression of calprotectin and its subunits, released during activation and/or death of granulocytes and monocytes. The purpose of this study was to quantify calprotectin and its subunits (MRPs) simultaneously in the GCF during the initial phase of experimentally induced gingivitis, and to examine their inter- and intra-individual variations.
Fifteen healthy non-smoking subjects, aged 18-30, were involved in this study. An initial hygiene phase (days -11 to 0) was followed by 10 days of undisturbed plaque accumulation. At days -11, -3, 0, 10, 11, clinical parameters were recorded and GCF samples collected with Durapore strips from 12 sites in each subject. Quantitative analyses of total proteins, MRP8/14, MRP14 and MRP8 were performed by ELISA procedures.
During the experimental phase with no oral hygiene (days 0-10), the clinical parameters Plaque Index, Gingival Index (GI) and bleeding on probing increased as expected, confirming that plaque accumulation leads to gingival inflammation. Levels of the MRPs were individually variable. They increased with plaque accumulation in one-half of the subjects, and decreased in the other subjects. The levels of MRP8/14 and MRP14 at subject recruitment (day -11) could predict a significant part of the GI at day 10. Only minute amounts of the subunits MRP8 and MRP14 were detected in comparison with the complex MRP8/14 throughout the experiment. Considerable variations were noted among sites within subjects.
The expression of calprotectin in the early phase of experimental gingivitis is variable between subjects, and two groups of subjects can be differentiated according to their response patterns. Clinical parameters at the very first visit (day -11) seemed to be different in the two response groups. The results of the present investigation indicate that the inflammatory response to plaque accumulation depends on the initial status of the subjects, which may not be leveled out by the introduction of perfect oral hygiene. Whether these patterns reflect a different susceptibility to periodontal diseases remains to be determined.
炎症性髓系相关蛋白MRP8/14,也称为钙卫蛋白,及其亚基MRP8和MRP14最近已在龈沟液(GCF)中被检测和鉴定。有人提出,根据在粒细胞和单核细胞激活和/或死亡期间释放的钙卫蛋白及其亚基表达的差异,可以区分炎症的类型和阶段。本研究的目的是在实验性龈炎的初始阶段同时定量GCF中的钙卫蛋白及其亚基(MRP),并检查它们的个体间和个体内差异。
15名年龄在18至30岁之间的健康非吸烟受试者参与了本研究。初始卫生阶段(第-11天至0天)之后是10天不受干扰的菌斑堆积。在第-11天、-3天、0天、10天、11天,记录临床参数,并用Durapore试纸从每个受试者的12个部位采集GCF样本。通过ELISA程序对总蛋白、MRP8/14、MRP14和MRP8进行定量分析。
在无口腔卫生的实验阶段(第0天至10天),菌斑指数、牙龈指数(GI)和探诊出血等临床参数如预期增加,证实菌斑堆积会导致牙龈炎症。MRP的水平存在个体差异。在一半的受试者中,它们随着菌斑堆积而增加,而在其他受试者中则下降。招募时(第-11天)的MRP8/14和MRP14水平可以预测第10天GI的很大一部分。在整个实验过程中,与复合物MRP8/14相比,仅检测到微量的亚基MRP8和MRP14。受试者内不同部位之间存在相当大的差异。
实验性龈炎早期钙卫蛋白的表达在受试者之间存在差异,并且可以根据其反应模式将两组受试者区分开来。两组反应组在首次就诊时(第-11天)的临床参数似乎有所不同。本研究结果表明,对菌斑堆积的炎症反应取决于受试者的初始状态,完美的口腔卫生引入可能无法消除这种差异。这些模式是否反映了对牙周疾病的不同易感性仍有待确定。